Mutations in the glucokinase (GCK) gene result in maturity-onset diabetes of the young (MODY). Pharmacotherapy is not effective in GCK MODY. Thus, nutritional intervention seems to be the only therapeutic option. This study evaluated the effect of the quantity of dietary carbohydrate on glucose levels in 10 GCK mutation carriers: seven with MODY and three with prediabetes. All patients were exposed to high-carbohydrate diets for 2 days and then switched to low-carbohydrate diets (60% versus 25% of the daily calorie intake) for another 2 days, after a 1-day washout. Glucose levels were assessed by continuous blood glucose monitoring. In patients with GCK MODY on high-carbohydrate diets, glucose levels were significantly higher, and more hyperglycaemic episodes occurred, compared with patients on low-carbohydrate diets. This short-term observational study suggested that diets with a modestly limited carbohydrate content may improve glycaemic control in patients with GCK MODY.
FajansSSBellGIPolonskyKS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med2001; 345: 971–980.
2.
FroguelPZoualiHVionnetN: Familial hyperglycaemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med1993; 328: 697–702.
3.
EllardSBeardsFAllenLI: A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia2000; 43: 250–253.
4.
CaoHShoreySRobinsonJ. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat2002; 20: 478–479.
5.
OsbakKKColcloughKSaint MartinC: Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat2009; 30: 1512–1526.
6.
MassaOMeschiFMunozA Cuesta. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). Diabetologia2001; 44: 898–905.
7.
BurkeCVBuettgerCWDavisEA: Cell-biological assessment of human glucokinase mutants causing maturity onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem J1999; 342: 345–352.
8.
BaliDSvetlanovALeeHW: Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem1995; 270: 21464–21467.
9.
BellGCuesta-MuñozAMatschinskyF: Glucokinase. In: Wiley Encyclopedia of Molecular Medicine (CreightonT, ed). New York: John Wiley, 2002; pp 1437–1441.
10.
CooperDKrawczakMAntonarakisS: The nature and mechanism of human gene mutations. In: The Metabolic and Molecular Basis of Inherited Disease (ScrivnerCRBeaudetALSlyWS, eds). New York: McGraw-Hill, 1995; pp 259–291.
11.
Gidh-JainMTakedaJXuLZ: Glucokinase mutations associated with noninsulin dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A1993; 90: 1932–1936.
12.
MillerSPAnandGRKarschniaEJ: Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes1999; 48: 1645–1651.
13.
SpyerGMacleodKMShepherdM: Pregnancy outcome in patients with raised blood glucose due to heterozygous glucokinase gene mutation. Diabet Med2009; 26: 14–18.
14.
SchnyderSMullisPEEllardS: Genetic testing for glucokinase mutations in clinically selected patients with MODY: worthwhile investment. Swiss Med Wkly2005; 135: 352–356.
MannJIDe LeeuwIHermansenK: Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis2004; 14: 373–394.
17.
FranzMJPowersMALeontosC: The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc2010; 110: 1852–1889.
18.
AlbertiKGZimmetPZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med1998; 15: 539–553.
19.
GannonMCNuttallFQ: Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes2004; 53: 2375–2382.
20.
HaltonTLLiuSMansonJE: Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr2008; 87: 339–346.
21.
VelhoGBlanchéHVaxillaireM: Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia1997; 40: 217–224.
